Meningitis vaccine study for infants and toddlers
Part of Infections clinical trials.
This study tests an experimental vaccine to protect babies and toddlers from meningitis (a serious infection of the brain and spinal cord). It checks how well the vaccine works and how safe it is in young children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 23 months old (depending on the study group).
- Your child was born at or after 27 weeks of pregnancy.
- Your child has not had meningitis or a weakened immune system.
- Your child has not had any neurological problems or Guillain-Barré syndrome.
- Your child has not received certain other vaccines or antibiotics just before the study.
- Your child is generally healthy and has no serious long-term illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches for any side effects or health changes after you receive the MenQuadfi vaccine, which protects against four types of meningococcal bacteria. Your doctor will follow up with you to make sure the vaccine is safe and working well.
This is an observational registry that collects information about pregnant people and their babies when MenQuadfi® (a meningitis vaccine) was given during pregnancy or shortly before pregnancy. It helps researchers understand what happens to women and offspring after this vaccine exposure.
This study tests a vaccine that protects against four common types of meningitis (groups A, C, Y, and W135) in toddlers aged 12–23 months. It helps researchers see if the vaccine is safe and works well for young children.
This trial tests a vaccine that protects against four types of meningococcal bacteria (groups A, C, W, and Y) in healthy babies aged 3 to 5 months. The vaccine is given to help prevent meningitis and other serious infections.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This study tests a new vaccine that may protect against several types of meningococcal bacteria, which can cause serious infections like meningitis. It is given as a single shot to healthy people aged 2 to 59 years.
Hear when a new Meningococcal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.